{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T06:41:35Z","timestamp":1709275295646},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.dld.2003.10.021","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:53:24Z","timestamp":1082714004000},"page":"423-425","source":"Crossref","is-referenced-by-count":0,"title":["Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"Lupascu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Armuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"De Pascalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Carloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.C.","family":"Lauritano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2003.10.021_BIB1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2003.10.021_BIB2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis","volume":"343","author":"Lipsky","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dld.2003.10.021_BIB3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn\u2019s disease","volume":"337","author":"Targan","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dld.2003.10.021_BIB4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dld.2003.10.021_BIB5","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/j.1572-0241.2002.06026.x","article-title":"Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis","volume":"97","author":"Su","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.10.021_BIB6","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.2001.04039.x","article-title":"Infliximab for refractory ulcerative colitis","volume":"96","author":"Chey","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.dld.2003.10.021_BIB7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/gut.52.7.998","article-title":"Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial","volume":"52","author":"Probert","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.dld.2003.10.021_BIB8","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/1529-0131(200112)44:12<2728::AID-ART459>3.0.CO;2-8","article-title":"Inflammatory bowel disease and spondyloarthropathy","volume":"44","author":"Smale","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.dld.2003.10.021_BIB9","first-page":"118","article-title":"Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab","volume":"29","author":"Brandt","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.dld.2003.10.021_BIB10","first-page":"959","article-title":"Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety","volume":"29","author":"Maksymowych","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.dld.2003.10.021_BIB11","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/rheumatology\/41.11.1280","article-title":"Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study","volume":"41","author":"Breban","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.dld.2003.10.021_BIB12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","article-title":"Efficacy of etanercept for the treatment of Crohn\u2019s disease related spondyloarthropathy but not colitis","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.dld.2003.10.021_BIB13","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","article-title":"An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia","volume":"17","author":"Reinisch","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.10.021_BIB14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","article-title":"Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease","volume":"97","author":"Mahadevan","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.10.021_BIB15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0016-5085(03)00983-1","article-title":"Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease","volume":"125","author":"Biancone","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2003.10.021_BIB16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1572-0241.2002.05514.x","article-title":"Treatment of acute uveitis associated with Crohn\u2019s disease and sacroileitis with infliximab","volume":"97","author":"Fries","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.10.021_BIB17","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","article-title":"Crohn\u2019s disease associated with spondyloarthropathy: effect of TNF-\u03b1 blockade with infliximab on articular symptoms","volume":"25","author":"Van den Bosch","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2003.10.021_BIB18","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1111\/j.1572-0241.2002.06064.x","article-title":"Improvement of arthritis and arthralgia after treatment with infliximab (remicade) in a German prospective, open-label, multicenter trial in refractory Crohn disease","volume":"97","author":"Herfarth","year":"2002","journal-title":"Am. J. Gastroenterol."}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1590865804000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1590865804000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T06:18:56Z","timestamp":1497593936000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865804000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1590865804000891"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2003.10.021","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}